Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel immunotherapies for psoriasis.

Khusru Asadullah1, Hans-Dieter Volk, Wolfram Sterry

  • 1Research Business Area Dermatology, Schering AG, D-13342, Berlin, Germany. khusru.asadullah@schering.de

Trends in Immunology
|January 22, 2002
PubMed
Summary

Novel immunomodulatory therapies for psoriasis show remarkable clinical trial results. These advancements offer new treatment options for T-cell-mediated autoimmune disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation.

Molecular therapy. Advances·2026
Same author

Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation.

Molecular therapy. Nucleic acids·2026
Same author

The Impact of Evaluation Strategy on Sepsis Prediction Model Performance Metrics in Intensive Care Data: Retrospective Cohort Study.

Journal of medical Internet research·2026
Same author

Prediction and risk evaluation of delirium after surgery in older patients: development and internal validation of an algorithm from the prospective BioCog cohort study.

British journal of anaesthesia·2026
Same author

mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cells.

Molecular therapy. Nucleic acids·2026
Same author

HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model.

Nature communications·2025

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Psoriasis pathophysiology insights reveal potential for targeted therapies.
  • Several novel systemic immunomodulatory therapies are in clinical development.

Purpose of the Study:

  • To review recent clinical trial results for novel psoriasis therapies.
  • To understand the role of specific mechanisms in psoriasis development.
  • To explore the broader impact on autoimmune disorder treatment.

Main Methods:

  • Review of clinical trial data for systemic immunomodulatory therapies.
  • Analysis of therapeutic targets including antigen presentation, T-cell activation, and cytokine modulation.

Main Results:

  • Remarkable results observed in recent clinical trials.
  • Identification of key mechanisms in psoriasis pathogenesis.
  • Validation of novel therapeutic targets.

Conclusions:

  • New therapeutic options for psoriasis are emerging.
  • Findings may impact the treatment of T-cell-mediated autoimmune disorders.
  • Psoriasis serves as a model for understanding broader autoimmune conditions.

Related Experiment Videos